Successful immunomodulatory therapy in castleman disease with paraneoplastic pemphigus vulgaris

Pathology and Oncology Research

Volumn 15, Issue 3, 2009, Pages 375-381

  Miltenyi, Zsofia ^a   Toth, Judit ^a   Gonda, Andrea ^a   Tar, Ildiko ^a   Remenyik, Eva ^a   Illes, Arpad ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Castleman disease; Immunmodulatory; PET CT

Indexed keywords

BORTEZOMIB; C REACTIVE PROTEIN; CA 125 ANTIGEN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; GANCICLOVIR; HYALIN; IMMUNOGLOBULIN G; INTERFERON; INTERLEUKIN 6; JO 1 ANTIBODY; METHYLPREDNISOLONE; PREDNISONE; RAMIPRIL; RITUXIMAB; THALIDOMIDE; TOCILIZUMAB; TUMOR MARKER; VINBLASTINE;

ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MEGADOSE; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; IMMUNOMODULATION; LAPAROTOMY; LYMPH NODE BIOPSY; MAINTENANCE DRUG DOSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC PEMPHIGUS; PATHOGENESIS; PRACTICE GUIDELINE; PROTEIN BLOOD LEVEL; RETROPERITONEAL TUMOR; TONGUE TUMOR; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; CYCLOSPORINE; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; IMMUNOMODULATION; IMMUNOSUPPRESSIVE AGENTS; NEOPLASM, RESIDUAL; PARANEOPLASTIC SYNDROMES; PEMPHIGUS; RETROPERITONEAL NEOPLASMS; THALIDOMIDE;

EID: 73449127597     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9133-x     Document Type: Article

References (18)

1. B Castleman VW Thowne 1954 Case records of the Massachuetts General Hospital weekly clinicopathological exercises: Case 40011 N Eng J Med 250 26 30
2. M van den Berge P Pauwels JJ Jakimowicz, et al. 2002 Hyaline vascular Castleman's disease: a case report and brief review of the literature Neth J Med 60 11 444 447 12685494
3. C Casper 2005 The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care Br J Haematol 129 3 17 10.1111/j.1365-2141.2004.05311.x 15801951 (Pubitemid 40524047)
4. E Oksenhendler G Carcelain Y Aoki, et al. 2000 High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients Blood 96 2069 2073 1:CAS:528:DC%2BD3cXms1Chs7s%3D 10979949
5. A Waterston M Bower 2004 Fifty years of multicentric Castleman's disease Acta Oncologica 43 698 704 10.1080/02841860410002752 15764213 (Pubitemid 40066010)
6. NL Harris S Swerdlow E Campo, et al. 2008 The World Health Organization (WHO) classification of lymphoid neoplasms: what's new? Ann Oncol 19 4 119
7. GJ Anhalt SC Kim JR Stanley, et al. 1990 Paraneoplastic pemphigus. An autoimmune mucocutaneus disease associated with neoplasia N Engl J Med 323 1729 1735 1:STN:280:DyaK3M%2FmtFyhtw%3D%3D 2247105
8. GJ Anhalt 2004 Paraneoplastic pemphigus J Investig Dermatol Symp Proc 9 1 29 33 10.1111/j.1087-0024.2004.00832.x 14870982 (Pubitemid 38096195)
9. A Dham BA Peterson 2007 Castleman disease Curr Opin Hematol 14 354 359 10.1097/MOH.0b013e328186ffab 1:CAS:528:DC%2BD2sXnsFSmur0%3D 17534161 (Pubitemid 46842810)
10. T Chorzelski T Hashimoto B Maciejewska, et al. 1999 Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis, and bronchiolitis obliterans J Am Acad Dermatol 41 3 3939 3400
11. N Nishimoto Y Kanakura K Aozasa, et al. 2005 Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease Blood 106 2627 2632 10.1182/blood-2004-12-4602 1:CAS:528:DC%2BD2MXhtFantbvL 15998837 (Pubitemid 41510733)
12. C Starkey N Joste FC Lee 2006 Near-total resolution of multicentric Castleman disease by prolonged treatment with thalidomid Am J Haematol 81 303 304 10.1002/ajh.20538 letter
13. FC Lee SH Merchant 2003 Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide Am J Hematol 73 48 53 10.1002/ajh.10310 12701121 (Pubitemid 36504579)
14. OV Nikolskaia CH Nousari GJ Anhalt 2003 Paraneoplastic pemphigus in association with Castleman's disease Br J Dermatol 149 1143 1151 10.1111/j.1365-2133.2003.05659.x 1:STN:280:DC%2BD3srptlyltw%3D%3D 14674890 (Pubitemid 38058089)
15. PR Cunha JR de Oliveira MJ Salles, et al. 2004 Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy Int J Dermatol 43 9 682 684 10.1111/j.1365-4632.2004.02174.x 15357753 (Pubitemid 39276299)
16. G Hess V Wagner A Kreft, et al. 2006 Effects of bortezomib on pro-inflammatory cytokine levels and transfusion dependency in a patient with multicentric Castleman disease Brit J Haematol 134 544 549 10.1111/j.1365-2141. 2006.06212.x 1:CAS:528:DC%2BD28XhtVWlu7vF (Pubitemid 44141721)
17. C Diéval F Bonnet S Mauclére, et al. 2007 Multicentric Castleman disease: Use of HHV8 viral load monitoring and positron emission tomography during follow-up Leuk Lymphoma 48 9 1881 1883 10.1080/ 10428190701509798 17786732 (Pubitemid 47386731)
18. Y Nakamura O Tokuyama A Muso, et al. 2002 Asymptomatic pelvic Castleman disease in an infertile woman: case report Arch Gynecol Obstet 269 156 158 10.1007/s00404-002-0420-6 14648185